IRVINE, CA -- (Marketwire) -- 10/14/09 -- Edwards Lifesciences Corporation (NYSE: EW), a
world leader in products and technologies to treat advanced cardiovascular
disease, plans to announce its operating results for the quarter ended
September 30, 2009 after the market closes on Wednesday, October 21, 2009
and will host a conference call at 5:00 p.m. ET that day to discuss its
results.
To participate in the conference call, dial (877) 407-8037 or (201)
689-8037. For 72 hours following the call, an audio replay can be accessed
by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995
and conference number 334198. The call will also be available via live or
archived webcast on the "Investor Relations" section of the Edwards web
site at www.edwards.com or
http://www.edwards.com/InvestorRelations/EventCalendar.htm.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring, with more than five decades of experience in
partnering with clinicians to develop life-saving innovations.
Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular
disease with its market-leading heart valve therapies, and critical care
and vascular technologies, which are sold in approximately 100 countries.
The company's global brands include Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz.
Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are
trademarks of Edwards Lifesciences Corporation and are registered in the
United States Patent and Trademark Office.
